Bioventus (BVS) Divestments (2022 - 2023)
Bioventus' (BVS) quarterly Divestments came in at -$46.4 million in Q4 2023, down 200.0% quarter-over-quarter from $46.4 million in Q3 2023.
Powered by 
Analysis
Bioventus (BVS) Divestments (2022 - 2023) Analysis & Trends
Bioventus (BVS) has reported Divestments for 2 consecutive years, with -$46.4 million the latest figure, recorded in Q4 2023.
- For the quarter ending Q4 2023, Divestments changed N/A year-over-year to -$46.4 million; the trailing twelve-month figure through Sep 2024 stood at -$46.4 million (down 232.97% YoY), and the FY2023 full-year result was -$11.5 million, up 89.03% from the prior year.
- Divestments eased to -$46.4 million in Q4 2023 per BVS's latest filing, from $46.4 million in the prior quarter.
- Across five years, Divestments topped out at $46.4 million in Q3 2023 and bottomed at -$104.8 million in Q4 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Divestments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | - |
| 10 | Bioventus | 923.70 Mn | 894.24 Mn | 105.67 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -46.40 Mn |
| Jul 1, 2023 | 46.40 Mn |
| Apr 1, 2023 | -11.51 Mn |
| Oct 1, 2022 | -104.84 Mn |